{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:24:28Z","timestamp":1793827468102,"version":"4.6.1"},"reference-count":163,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.1080\/17512433.2023.2181157","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:16:06Z","timestamp":1676884566000},"page":"207-217","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Safety of drugs used for the treatment of migraine during pregnancy: a narrative review"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-2249","authenticated-orcid":false,"given":"Jessica A","family":"Spiteri","sequence":"first","affiliation":[{"name":"Department of Anaesthesia, Intensive Care and Pain Medicine, Mater Dei Hospital, Triq Dun Karm, Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Camilleri","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, University of Malta, Msida MSD, Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8648-8961","authenticated-orcid":false,"given":"Carlo","family":"Piccinni","sequence":"additional","affiliation":[{"name":"Fondazione Ricerca e Salute (ReS)-Research and Health Foundation, Casalecchio di Reno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-169X","authenticated-orcid":false,"given":"Janet","family":"Sultana","sequence":"additional","affiliation":[{"name":"Exeter College of Medicine and Health, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01184.x"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01208-0"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64240-0.00011-8"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03792-9"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2012.04.001"},{"issue":"1","key":"cit0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/head.13456","volume":"59","author":"American Headache Society","year":"2019","journal-title":"Headache"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10534-5"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0744-2"},{"key":"cit0011","first-page":"w13936","volume":"144","author":"Csajka C","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0322-5"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0816-0"},{"key":"cit0014","unstructured":"National Institute for Health and Care Excellence [Internet]. London [UK]: NICE. Headaches in over 12s: diagnosis and management Clinical guideline; [cited 2021 Dec 17]. Available from: https:\/\/www.nice.org.uk\/guidance\/cg150"},{"key":"cit0015","unstructured":"British Association for the Study of Headache. National headache Management System for Adults 2019. London(UK): British Association for the Study of Headache; 2019"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535d0c"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535d20"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/head.12499"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153"},{"issue":"2","key":"cit0020","first-page":"S1","volume":"39","author":"Pringsheim T","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100118943"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02748.x"},{"key":"cit0023","unstructured":"UK Teratology Information Service [Internet]. England (UK): Public Health England; [cited 2021 Feb 4]. Available from; http:\/\/www.uktis.org\/html\/about_us.html"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1111\/head.13665"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.0608"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00833"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0627-x"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0338"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14363"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0731"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2822"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130733"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)90790-3"},{"key":"cit0034","unstructured":"European Medicines Agency Committee for Medicinal Products for Human Use (CHMP). Assessment Report: Referral under Article 30 of Directive 2001\/83\/EC, Saroten and associated names, INN\/active substance: amitriptyline. European Medicines Agency London (UK); 2017. (Procedure number: EMEA\/H\/A-30\/1430)"},{"key":"cit0035","unstructured":"Medicines.org.uk [Internet]. Devon [UK]: Accord-UK LTD: Summary of Product Characteristics: Amitriptyline Hydrochloride 10mg Tablet BP [cited 2021 Feb 2]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/5698\/smpc#gref"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013372"},{"issue":"4","key":"cit0037","first-page":"CD002919","volume":"4","author":"Banzi R","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0558-1"},{"issue":"11","key":"cit0039","first-page":"CD010224","volume":"11","author":"Weston J","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210716111814"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.4290"},{"key":"cit0042","unstructured":"Food and Drug Administration [Internet]. Virginia(VA): FDA Drug Safety Communication: Valproate Anti-seizure Products Contraindicated for Migraine Prevention in Pregnant Women due to Decreased IQ Scores in Exposed Children; 2011 [cited 2022 Oct 9]. Available from: http:\/\/wayback.archive-it.org\/7993\/20170113093202\/http:\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM350748.pdf"},{"key":"cit0043","unstructured":"European Medicines Agency [Internet]. London (UK): New measures to avoid valproate exposure in pregnancy endorsed; 2018 [cited 2022 Oct 9]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/valproate-article-31-referral-new-measures-avoid-valproate-exposure-pregnancy-endorsed_en-0.pdf"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0845-1"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.1269"},{"key":"cit0046","unstructured":"Shamliyan TA, Kane RL, Taylor FR. Migraine in Adults: Preventive Pharmacologic Treatments [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr. Report No.: 13-EHC068-EF."},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.196352"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002233"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0559-0"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012093"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.29"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410364676"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410364677"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0976-1"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-13-00477"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3920"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01196-1"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071429"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1177\/03331024211037277"},{"issue":"8","key":"cit0060","first-page":"713","volume":"325","author":"Slomski A","year":"2021","journal-title":"JAMA"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01633-3"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01431-x"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6558.1329"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1481"},{"issue":"5","key":"cit0065","first-page":"573","volume":"21","author":"Fei X","year":"2012","journal-title":"Adv Clin Exp Med"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod67.2.624"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.05.013"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04931-3"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420983292"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00409-9"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0634-9"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004365"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.02.100"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12595"},{"issue":"4","key":"cit0075","first-page":"CD008040","volume":"2013","author":"Derry S","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0076","volume-title":"Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment","author":"Schaefer C","year":"2014","edition":"4"},{"key":"cit0077","volume-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","author":"Briggs GG","year":"2017","edition":"11"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex047"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.106"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq323"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der474"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2011.01211.x"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12745"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt183"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.4914"},{"key":"cit0086","unstructured":"European Medicines Agency [Internet]. London (UK): Pharmacovigilance Risk Assessment Committee (PRAC); minutes of the meeting on 5-8 May 2014; [cited 2021 Feb 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes-prac-meeting-5-8-may-2014_en.pdf"},{"key":"cit0087","unstructured":"Food and Drug Administration [Internet].Virginia(VA): FDA Drug Safety Communication: FDA has reviewed possible risks of pain medicine use during pregnancy; 2015 [cited 2022 Mar 24]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-has-reviewed-possible-risks-pain-medicine-use-during-pregnancy"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3840"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2018.01.003"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy086"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.3259"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.11.958"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02151.x"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.065"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv366"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2012-303043"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01090-2018"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31828a4b54"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000550"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69255-6"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1159\/000350979"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2020.09.003"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.06.002"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110454"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1016\/S0890-6238(01)00137-X"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20085"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.11.019"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181f20bed"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022174"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-013-9831-x"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2385-1"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2018.02.007"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90918-6"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G428"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00004"},{"key":"cit0116","unstructured":"Food and Drug Administration [Internet]. Virginia (VA): FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid; [cited 2021, Apr 1]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1338-3"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311253292202"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1998.tb02949.x"},{"key":"cit0120","unstructured":"Food and Drug Administration [Internet]. Virginia (VA): Centre for Drug Evaluation and Research Approval Package for Elyxyb Oral Solution; 2020 [cited 2022 Feb 14]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2020\/212157Orig1s000Approv.pdf"},{"key":"cit0121","unstructured":"Dr. Reddy\u2019s Laboratories Limited [Internet]. Hyderabad (IN); US Food and Drug Administration. Elyxyb (celecoxib) oral solution: Full Prescribing Information; [cited Mar 15, 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/212157s000lbl.pdf"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7281.266"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.255"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1080\/15287398209530252"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1002\/jez.1402160111"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420200215"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-3219-0_38"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)93025-7"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.127376"},{"key":"cit0130","unstructured":"Scottish Intercollegiate Guidelines Network [Internet]. Scotland(UK); Scottish Network Guidelines Intercollegiate (SIGN). Improving patient care through evidence-based guidelines; [cited 2021 Feb 12]. Available from: http:\/\/www.sign.ac.uk"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417724152"},{"key":"cit0132","doi-asserted-by":"publisher","DOI":"10.1111\/head.12375"},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01619.x"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.2165\/11590370-000000000-00000"},{"key":"cit0135","unstructured":"Organon [Internet]. Jersey City (NJ); Organon LLC. MAXALT\u00ae and MAXALT-MLT\u00ae Summary of Product Characteristics; [cited 2021 Feb 2]. Available from: https:\/\/www.organon.com\/product\/usa\/pi_circulars\/m\/maxalt\/maxalt_pi.pdf"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.1111\/head.12500"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12253"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-02991-0"},{"key":"cit0139","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S31392"},{"issue":"9","key":"cit0140","first-page":"CD007575","volume":"2015","author":"Matthews A","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0141","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.122596"},{"key":"cit0142","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.6.6.685"},{"key":"cit0143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257584"},{"key":"cit0144","unstructured":"Alaven Pharmaceutical LLC [Internet]. Minnesota (MN); US Food and Drug Administration. Reglan (Metoclopramide): Full Prescribing Information; [cited 2021 Mar 15]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/017854s062lbl.pdf"},{"key":"cit0145","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2010.505601"},{"key":"cit0146","unstructured":"Food and Drug Administration [Internet]. Virginia (VA): FDA Warns Against Women Using Unapproved Drug, Domperidone, to Increase Milk Production; 2004 [cited 2021 Mar 16]. Available from: https:\/\/www.fda.gov\/drugs\/information-drug-class\/fda-talk-paper-fda-warns-against-women-using-unapproved-drug-domperidone-increase-milk-production"},{"key":"cit0147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.03.020"},{"key":"cit0148","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.01.013"},{"key":"cit0149","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2012.02140.x"},{"key":"cit0150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.12.039"},{"key":"cit0151","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1069-5"},{"key":"cit0152","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mku049"},{"key":"cit0153","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.1.9"},{"key":"cit0154","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0592-1"},{"key":"cit0155","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02901.x"},{"key":"cit0156","unstructured":"Eli Lilly and Company [Internet]. Reyvow\u2122 (Lasmiditan): Full prescribing information. Indianapolis [IN]; US Food and Drug Administration; [cited 2021 Sep 14]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211280s000lbl.pdf"},{"key":"cit0157","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.143040"},{"key":"cit0158","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwz214"},{"key":"cit0159","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1833"},{"key":"cit0160","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.062810"},{"key":"cit0161","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420941839"},{"key":"cit0162","unstructured":"Food and Drug Administration [Internet].Virginia (VA): Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials. Guidance for Industry; [cited 2021 Mar 24]. Available from: https:\/\/www.fda.gov\/media\/112195\/download"},{"key":"cit0163","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.08.016"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2023.2181157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T06:00:50Z","timestamp":1701928850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2023.2181157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":163,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,4]]}},"alternative-id":["10.1080\/17512433.2023.2181157"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2023.2181157","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}